XML 129 R115.htm IDEA: XBRL DOCUMENT v3.6.0.2
Condensed Consolidating Financial Information (Condensed Consolidating Statement of Cash Flows) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Jan. 02, 2016
Cash flows from operating activities:    
Net cash provided by (used in) operating activities of continuing operations $ 49,383 $ 16,226
Net cash (used in) provided by operating activities of discontinued operations (10,512) 15,968
Net cash provided by operating activities 38,871 32,194
Cash flows from investing activities:    
Cost of business acquisitions, net of cash acquired 0 (1,996)
Capital expenditures (41,137) (25,928)
Proceeds from sale of property, plant and equipment 8,330 8,558
Proceeds from sale of assets 2,000 2,180
Net cash used in investing activities of continuing operations (30,807) (17,186)
Net cash provided by (used in) investing activities of discontinued operations 95,866 (2,282)
Net cash provided by (used in) investing activities 65,059 (19,468)
Cash flows from financing activities:    
Proceeds from issuance of 4% senior secured notes due 2021 50,000 0
Payment of financing related costs and expenses and debt issuance discounts (11,576) (1,596)
Proceeds from issuance of other long-term debt 0 12,500
Repayments of other long-term debt (5,578) (16,545)
Repayment of 11.5% senior notes due 2017 (24,725) (22,720)
Repayment of 7% senior exchangeable notes due 2017 (45,903) 0
Repayment of 8.500% junior secured priority notes due 2022 (4,550) 0
Purchase and retirement of common stock upon vesting of restricted stock units (346) (216)
Borrowings under asset-based revolving credit facility due 2021 474,300 468,300
Repayments under asset-based revolving credit facility due 2021 (540,800) (454,800)
Intercompany advances 0 0
Net cash (used in) provided by financing activities of continuing operations (109,178) (15,077)
Net cash used in financing activities of discontinued operations (8) (473)
Net cash used in financing activities (109,186) (15,550)
Effect of exchange rate changes on cash and cash equivalents 232 (1,213)
Net decrease in cash and cash equivalents (5,024) (4,037)
Cash and cash equivalents at beginning of period 10,556 14,593
Cash and cash equivalents at end of period 5,532 10,556
Less cash and cash equivalents of discontinued operations 0 (2,771)
Cash and cash equivalents of continuing operations at end of period 5,532 7,785
Parent Company [Member]    
Cash flows from operating activities:    
Net cash provided by (used in) operating activities of continuing operations 1,468 1,636
Net cash (used in) provided by operating activities of discontinued operations 0 0
Net cash provided by operating activities 1,468 1,636
Cash flows from investing activities:    
Cost of business acquisitions, net of cash acquired   0
Capital expenditures 0 0
Proceeds from sale of property, plant and equipment 0 0
Proceeds from sale of assets 0 0
Net cash used in investing activities of continuing operations 0 0
Net cash provided by (used in) investing activities of discontinued operations 0 0
Net cash provided by (used in) investing activities 0 0
Cash flows from financing activities:    
Proceeds from issuance of 4% senior secured notes due 2021 0  
Payment of financing related costs and expenses and debt issuance discounts 0 0
Proceeds from issuance of other long-term debt   0
Repayments of other long-term debt 0 0
Repayment of 11.5% senior notes due 2017 0 0
Repayment of 7% senior exchangeable notes due 2017 0  
Repayment of 8.500% junior secured priority notes due 2022 0  
Purchase and retirement of common stock upon vesting of restricted stock units (346) (216)
Borrowings under asset-based revolving credit facility due 2021 0 0
Repayments under asset-based revolving credit facility due 2021 0 0
Intercompany advances (1,122) (1,420)
Net cash (used in) provided by financing activities of continuing operations (1,468) (1,636)
Net cash used in financing activities of discontinued operations 0 0
Net cash used in financing activities (1,468) (1,636)
Effect of exchange rate changes on cash and cash equivalents 0 0
Net decrease in cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period 0 0
Less cash and cash equivalents of discontinued operations   0
Cash and cash equivalents of continuing operations at end of period 0 0
Subsidiary Issuer [Member]    
Cash flows from operating activities:    
Net cash provided by (used in) operating activities of continuing operations (93,513) (110,318)
Net cash (used in) provided by operating activities of discontinued operations 0 0
Net cash provided by operating activities (93,513) (110,318)
Cash flows from investing activities:    
Cost of business acquisitions, net of cash acquired   (1,996)
Capital expenditures (19,281) (18,448)
Proceeds from sale of property, plant and equipment 8,189 7,673
Proceeds from sale of assets 0 0
Net cash used in investing activities of continuing operations (11,092) (12,771)
Net cash provided by (used in) investing activities of discontinued operations 0 0
Net cash provided by (used in) investing activities (11,092) (12,771)
Cash flows from financing activities:    
Proceeds from issuance of 4% senior secured notes due 2021 50,000  
Payment of financing related costs and expenses and debt issuance discounts (11,576) (1,596)
Proceeds from issuance of other long-term debt   12,500
Repayments of other long-term debt (5,381) (17,721)
Repayment of 11.5% senior notes due 2017 (24,725) (22,720)
Repayment of 7% senior exchangeable notes due 2017 (45,903)  
Repayment of 8.500% junior secured priority notes due 2022 (4,550)  
Purchase and retirement of common stock upon vesting of restricted stock units 0 0
Borrowings under asset-based revolving credit facility due 2021 474,300 468,300
Repayments under asset-based revolving credit facility due 2021 (540,800) (454,800)
Intercompany advances 212,360 133,719
Net cash (used in) provided by financing activities of continuing operations 103,725 117,682
Net cash used in financing activities of discontinued operations 0 0
Net cash used in financing activities 103,725 117,682
Effect of exchange rate changes on cash and cash equivalents 0 0
Net decrease in cash and cash equivalents (880) (5,407)
Cash and cash equivalents at beginning of period 5,558 10,965
Cash and cash equivalents at end of period 4,678 5,558
Less cash and cash equivalents of discontinued operations   0
Cash and cash equivalents of continuing operations at end of period 4,678 5,558
Guarantor Subsidiaries [Member]    
Cash flows from operating activities:    
Net cash provided by (used in) operating activities of continuing operations 142,605 122,254
Net cash (used in) provided by operating activities of discontinued operations (10,074) 15,230
Net cash provided by operating activities 132,531 137,484
Cash flows from investing activities:    
Cost of business acquisitions, net of cash acquired   0
Capital expenditures (21,120) (6,921)
Proceeds from sale of property, plant and equipment 141 885
Proceeds from sale of assets 2,000 2,180
Net cash used in investing activities of continuing operations (18,979) (3,856)
Net cash provided by (used in) investing activities of discontinued operations 89,379 (2,282)
Net cash provided by (used in) investing activities 70,400 (6,138)
Cash flows from financing activities:    
Proceeds from issuance of 4% senior secured notes due 2021 0  
Payment of financing related costs and expenses and debt issuance discounts 0 0
Proceeds from issuance of other long-term debt   0
Repayments of other long-term debt (197) 1,176
Repayment of 11.5% senior notes due 2017 0 0
Repayment of 7% senior exchangeable notes due 2017 0  
Repayment of 8.500% junior secured priority notes due 2022 0  
Purchase and retirement of common stock upon vesting of restricted stock units 0 0
Borrowings under asset-based revolving credit facility due 2021 0 0
Repayments under asset-based revolving credit facility due 2021 0 0
Intercompany advances (203,366) (130,879)
Net cash (used in) provided by financing activities of continuing operations (203,563) (129,703)
Net cash used in financing activities of discontinued operations (8) (473)
Net cash used in financing activities (203,571) (130,176)
Effect of exchange rate changes on cash and cash equivalents 316 (1,690)
Net decrease in cash and cash equivalents (324) (520)
Cash and cash equivalents at beginning of period 324 844
Cash and cash equivalents at end of period 0 324
Less cash and cash equivalents of discontinued operations   (89)
Cash and cash equivalents of continuing operations at end of period 0 235
Non-Guarantor Subsidiaries [Member]    
Cash flows from operating activities:    
Net cash provided by (used in) operating activities of continuing operations (1,177) 2,654
Net cash (used in) provided by operating activities of discontinued operations (438) 738
Net cash provided by operating activities (1,615) 3,392
Cash flows from investing activities:    
Cost of business acquisitions, net of cash acquired   0
Capital expenditures (736) (559)
Proceeds from sale of property, plant and equipment 0 0
Proceeds from sale of assets 0 0
Net cash used in investing activities of continuing operations (736) (559)
Net cash provided by (used in) investing activities of discontinued operations 6,487 0
Net cash provided by (used in) investing activities 5,751 (559)
Cash flows from financing activities:    
Proceeds from issuance of 4% senior secured notes due 2021 0  
Payment of financing related costs and expenses and debt issuance discounts 0 0
Proceeds from issuance of other long-term debt   0
Repayments of other long-term debt 0 0
Repayment of 11.5% senior notes due 2017 0 0
Repayment of 7% senior exchangeable notes due 2017 0  
Repayment of 8.500% junior secured priority notes due 2022 0  
Purchase and retirement of common stock upon vesting of restricted stock units 0 0
Borrowings under asset-based revolving credit facility due 2021 0 0
Repayments under asset-based revolving credit facility due 2021 0 0
Intercompany advances (7,872) (1,420)
Net cash (used in) provided by financing activities of continuing operations (7,872) (1,420)
Net cash used in financing activities of discontinued operations 0 0
Net cash used in financing activities (7,872) (1,420)
Effect of exchange rate changes on cash and cash equivalents (84) 477
Net decrease in cash and cash equivalents (3,820) 1,890
Cash and cash equivalents at beginning of period 4,674 2,784
Cash and cash equivalents at end of period 854 4,674
Less cash and cash equivalents of discontinued operations   (2,682)
Cash and cash equivalents of continuing operations at end of period 854 1,992
Eliminations [Member]    
Cash flows from operating activities:    
Net cash provided by (used in) operating activities of continuing operations 0 0
Net cash (used in) provided by operating activities of discontinued operations 0 0
Net cash provided by operating activities 0 0
Cash flows from investing activities:    
Cost of business acquisitions, net of cash acquired   0
Capital expenditures 0 0
Proceeds from sale of property, plant and equipment 0 0
Proceeds from sale of assets 0 0
Net cash used in investing activities of continuing operations 0 0
Net cash provided by (used in) investing activities of discontinued operations 0 0
Net cash provided by (used in) investing activities 0 0
Cash flows from financing activities:    
Proceeds from issuance of 4% senior secured notes due 2021 0  
Payment of financing related costs and expenses and debt issuance discounts 0 0
Proceeds from issuance of other long-term debt   0
Repayments of other long-term debt 0 0
Repayment of 11.5% senior notes due 2017 0 0
Repayment of 7% senior exchangeable notes due 2017 0  
Repayment of 8.500% junior secured priority notes due 2022 0  
Purchase and retirement of common stock upon vesting of restricted stock units 0 0
Borrowings under asset-based revolving credit facility due 2021 0 0
Repayments under asset-based revolving credit facility due 2021 0 0
Intercompany advances 0 0
Net cash (used in) provided by financing activities of continuing operations 0 0
Net cash used in financing activities of discontinued operations 0 0
Net cash used in financing activities 0 0
Effect of exchange rate changes on cash and cash equivalents 0 0
Net decrease in cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period 0 0
Less cash and cash equivalents of discontinued operations   0
Cash and cash equivalents of continuing operations at end of period $ 0 $ 0